Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 07/25 05:37:13 pm
94.525 USD   -2.10%
02:45p CVS HEALTH : To Hold Second Quarter 2016 Conference Call
02:31p CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescr..
07/23 CVS HEALTH : St. Johns Investment Management Company buys $1,105,897..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

CVS Caremark 4th-Quarter Profit Rose 2.6% Amid Continued Sales Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/06/2013 | 01:52pm CEST
   By Tess Stynes 
 

CVS Caremark Corp.'s (>> CVS Caremark Corporation) fourth-quarter earnings rose 2.6% as the company reported revenue growth in its pharmacy-services and retail drugstore operations.

For the year, the company raised its forecast for per-share adjusted earnings from continuing operations by two cents and now expects $3.86 to $4.

CVS's retail pharmacy business gained customers last year in the wake of a contract dispute between rival Walgreen Co.'s (>> Walgreen Company) and pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that has since been resolved.

A wave of major generic drugs introductions is having a mixed effect on the industry. Though the copycat drugs carry higher margins than branded products, they command lower prices, hurting sales revenue.

CVS Caremark reported a profit of $1.13 billion, or 90 cents a share, up from $1.1 billion, or 81 cents a share, a year earlier. Excluding debt-extinguishment losses, acquisition-related charges and other items, adjusted earnings from continuing operations were $1.14. Revenue increased 11% to $31.39 billion.

Analysts polled by Thomson Reuters most recently projected earnings of $1.10 on revenue of $31.13 billion.

Revenue in the larger pharmacy-services business climbed 17% to $18.6 billion, reflecting new client starts, higher prices and growth of its Medicare Part D program. Pharmacy network claims processed rose 6.5%.

On the retail side, revenue increased 5.1% to $16.3 billion. Same-store sales were up 4% from a year earlier, as pharmacy same-store sales also improved by 4%. Same-store sales in the front end of the store grew 3.9%.

Shares closed Tuesday at $51.72 and were inactive premarket.

Write to Tess Stynes at tess.stynes@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
02:45p CVS HEALTH : To Hold Second Quarter 2016 Conference Call
02:31p CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescription At Al..
07/23 CVS HEALTH : St. Johns Investment Management Company buys $1,105,897 stake in CV..
07/22 CVS HEALTH CORPORATION : To Hold Second Quarter 2016 Conference Call
07/22 CVS HEALTH : Rep. Lipinski Announces Installation of Drop Box for Unwanted Presc..
07/21 CVS HEALTH : Lipinski Announces Installation of Drop Box for Unwanted Prescripti..
07/19 CVS HEALTH CORP : ex-dividend day
07/18 CVS HEALTH : Free Clinic receives $10,000 grant from CVS
07/15 CVS HEALTH : Specialty Pharmacy Facility Opens in Orlando
07/15 CVS HEALTH : Research Institute Study Shows that Medication Reconciliation Progr..
More news
Sector news : Drug Retailers - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/21DJSINOPHARM : to Inject Certain Assets Into China National Medicines for CNY5.37 B..
07/18DJStarbucks Widens Workers' Health-Insurance Options
07/13DJWALGREENS BOOTS ALLIANCE : Boosts Its Quarterly Dividend 4.2%
More sector news : Drug Retailers - NEC
News from SeekingAlpha
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/22 CVS HEALTH : Stock Valuations Are Compelling
07/21 CONSUMER STAPLES : Finding Value In An Expensive Sector
07/21 The Happy Gilmore Market And My Search For Attractive Multiples At Today's Pr..
07/21 Risk-Reward Of The Market - Cramer's Mad Money (7/20/16)
Advertisement
Financials ($)
Sales 2016 181 303 M
EBIT 2016 10 754 M
Net income 2016 5 791 M
Debt 2016 25 246 M
Yield 2016 1,69%
P/E ratio 2016 17,77
P/E ratio 2017 15,50
EV / Sales 2016 0,71x
EV / Sales 2017 0,65x
Capitalization 103 697 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 112 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-1.25%103 697
WALGREENS BOOTS ALLIAN..-4.47%88 047
EXPRESS SCRIPTS HOLDIN..-9.78%49 903
MCKESSON CORPORATION-0.33%44 365
CARDINAL HEALTH INC-7.03%27 039
AMERISOURCEBERGEN CORP..-17.21%18 533
More Results